Brief: Galecto Resumes Recruitment In Phase 2B Global GALACTIC-1 Trial Of GB0139
July 13 (Reuters) - Galecto Inc GLTO.O :
* GALECTO RESUMES RECRUITMENT IN PHASE 2B GLOBAL GALACTIC-1
TRIAL
OF GB0139 FOR IDIOPATHIC PULMONARY FIBROSIS
Source text for Eikon: ID:nGNX78bJDX
Further company coverage: GLTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Damora Therapeutics
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. RESEARCH ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics
U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology
Brief: Damora Therapeutics Reports First Quarter 2026 Financial Results
Brief: Damora Therapeutics: Lori Firmani To Cease Serving As CFO Effective May 1, 2026 - SEC Filing